A detailed history of Smith, Salley & Associates transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 10,393 shares of IQV stock, worth $2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,393
Previous 10,016 3.76%
Holding current value
$2 Million
Previous $2.12 Million 16.25%
% of portfolio
0.17%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$206.81 - $251.55 $77,967 - $94,834
377 Added 3.76%
10,393 $2.46 Million
Q2 2024

Jul 29, 2024

BUY
$211.18 - $248.87 $226,173 - $266,539
1,071 Added 11.97%
10,016 $2.12 Million
Q1 2024

May 02, 2024

BUY
$208.23 - $259.1 $441,031 - $548,773
2,118 Added 31.02%
8,945 $2.26 Million
Q4 2023

Jan 24, 2024

BUY
$177.16 - $232.73 $60,234 - $79,128
340 Added 5.24%
6,827 $1.58 Million
Q3 2023

Oct 27, 2023

BUY
$196.75 - $231.96 $83,028 - $97,887
422 Added 6.96%
6,487 $1.28 Million
Q2 2023

Aug 04, 2023

BUY
$183.66 - $224.77 $12,672 - $15,509
69 Added 1.15%
6,065 $1.36 Million
Q1 2023

May 03, 2023

SELL
$188.0 - $240.65 $13,724 - $17,567
-73 Reduced 1.2%
5,996 $1.19 Million
Q4 2022

Feb 03, 2023

SELL
$172.45 - $226.53 $3,621 - $4,757
-21 Reduced 0.34%
6,069 $1.24 Million
Q3 2022

Nov 01, 2022

BUY
$181.14 - $248.26 $79,158 - $108,489
437 Added 7.73%
6,090 $1.1 Million
Q2 2022

Aug 01, 2022

SELL
$196.45 - $252.29 $15,323 - $19,678
-78 Reduced 1.36%
5,653 $1.23 Million
Q1 2022

May 10, 2022

SELL
$210.56 - $273.58 $161,710 - $210,109
-768 Reduced 11.82%
5,731 $1.33 Million
Q4 2021

Feb 10, 2022

BUY
$238.37 - $282.61 $203,329 - $241,066
853 Added 15.11%
6,499 $1.83 Million
Q3 2021

Nov 05, 2021

BUY
$239.54 - $265.23 $207,920 - $230,219
868 Added 18.17%
5,646 $1.35 Million
Q2 2021

Aug 09, 2021

BUY
$198.06 - $246.77 $94,276 - $117,462
476 Added 11.06%
4,778 $1.16 Million
Q1 2021

Apr 30, 2021

BUY
$173.0 - $194.59 $3,114 - $3,502
18 Added 0.42%
4,302 $831,000
Q4 2020

Jan 28, 2021

BUY
$153.99 - $180.39 $159,533 - $186,884
1,036 Added 31.9%
4,284 $768,000
Q3 2020

Nov 05, 2020

BUY
$141.28 - $169.75 $10,737 - $12,901
76 Added 2.4%
3,248 $512,000
Q2 2020

Aug 04, 2020

BUY
$100.04 - $153.06 $49,319 - $75,458
493 Added 18.4%
3,172 $450,000
Q1 2020

Apr 24, 2020

BUY
$84.0 - $166.11 $32,676 - $64,616
389 Added 16.99%
2,679 $289,000
Q4 2019

Jan 27, 2020

BUY
$137.59 - $155.95 $18,024 - $20,429
131 Added 6.07%
2,290 $354,000
Q3 2019

Oct 30, 2019

BUY
$148.25 - $161.46 $33,208 - $36,167
224 Added 11.58%
2,159 $323,000
Q2 2019

Jul 12, 2019

BUY
$132.28 - $160.9 $18,122 - $22,043
137 Added 7.62%
1,935 $311,000
Q1 2019

May 03, 2019

BUY
$109.96 - $144.45 $197,708 - $259,721
1,798 New
1,798 $259,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $35.8B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.